MPN Research Foundation

The mission of the MPN Research Foundation is to stimulate original research in pursuit of new treatments — and eventually a cure — for the blood cancers polycythemia vera, essential thrombocythemia, and myelofibrosis, known collectively as myeloproliferative neoplasms (MPN).

Through a combination of MPN cancer research, advocacy and education, we bring together patients, researchers, and clinicians around the common goal of realizing new treatment options and ultimately, a cure for MPNs.

CLINICAL TRIAL FINDER – MPN Research Foundation

Connect with us:

Latest from MPN Research Foundation

Highlights and Key Takeaways from the 2021 MPN Roundtable

March 14, 2022

Article

IMPACT@21

February 14, 2022

Article

The internet was in its infancy when the MPN Research Foundation was founded.

MPN Research Foundation Releases Voice of the Patient Report on MPNs

February 14, 2022

Article

The MPN Research Foundation is thrilled to share with you the "Voice of the Patient Report on Myeloproliferative Neoplasms."

3-Year Global MPN Interferon Initiative Report Released by MPN Research Foundation

February 14, 2022

Article

Studies offer insight into who might benefit from interferon for treatment of a rare blood cancer.

Educated Patient® Webinar: Understanding Myeloproliferative Neoplasms (MPNs) and Treatment Options

October 28, 2021

Video

View the full CURE® Educated Patient® Webinar: Understanding Myeloproliferative Neoplasms (MPNs) and Treatment Options on demand.

Becoming an Informed Patient With Rare Cancer

October 25, 2021

Article

Dr. Gabriela Hobbs offers insight into a rare cancer, myeloproliferative neoplasms, to help patients learn more during their treatment journey.